Lindis Biotech & Pharmanovia Get EU Approval in Malignant Ascites
13 Feb 2025 //
ACCESSWIRE
Lindis Licenses Catumaxomab to Pharmanovia for Commercialization
19 Nov 2024 //
ACCESSWIRE
Lindis Biotech Receives Positive CHMP Opinion For Korjuny® in EU
21 Oct 2024 //
ACCESSWIRE